4//SEC Filing
Schoch Charles 4
Accession 0000950170-25-089473
CIK 0001841387other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:30 PM ET
Size
5.5 KB
Accession
0000950170-25-089473
Insider Transaction Report
Form 4
Schoch Charles
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+50,000→ 50,000 totalExercise: $4.75Exp: 2035-06-20→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. 25% of the shares underlying this option shall vest and become exercisable on June 20, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0002007349
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:30 PM ET
- Size
- 5.5 KB